.png){kind=icon}
.png){kind=icon}
Return
Survivorship: Cognitive Function, Version 1.2014
.png){kind=icon}
OA
AI
DOI：10.6004/jnccn.2014.0094.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Cognitive impairment is a common complaint among cancer survivors and may be a consequence of the tumors themselves or direct effects of cancer-related treatment (eg, chemotherapy, endocrine therapy, radiation). For some survivors, symptoms persist over the long term and, when more severe, can impact quality of life and function. This section of the NCCN Guidelines for Survivorship provides assessment, evaluation, and management recommendations for cognitive dysfunction in survivors. Nonpharmacologic interventions (eg, instruction in coping strategies; management of distress, pain, sleep disturbances, and fatigue; occupational therapy) are recommended, with pharmacologic interventions as a last line of therapy in survivors for whom other interventions have been insufficient.
Keywords:
STEM-CELL TRANSPLANTATION
QUALITY-OF-LIFE
BREAST-CANCER
ADJUVANT CHEMOTHERAPY
DOUBLE-BLIND
LONGITUDINAL ASSESSMENT
DYSFUNCTION
WOMEN
METAANALYSIS
TUMORS
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
J
IF:
16.4
Papers:
2.8K
Citations:
1.5W
Organization
View more organizations